ISL1 | ISL LIM homeobox 1 | Transcription factors
| | | | | Tissue enhanced |
KLK15 | Kallikrein-related peptidase 15 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
LGALS4 | Lectin, galactoside-binding, soluble, 4 | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
LGALS9B | Lectin, galactoside-binding, soluble, 9B | | | | | | Tissue enhanced |
LGALS9C | Lectin, galactoside-binding, soluble, 9C | | | | | | Tissue enhanced |
MIA2 | Melanoma inhibitory activity 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
MISP | Mitotic spindle positioning | Cytoskeleton related proteins
| | | | | Tissue enhanced |
MLPH | Melanophilin | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
MME | Membrane metallo-endopeptidase | Cancer-related genes Candidate cardiovascular disease genes CD markers Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MUC1 | Mucin 1, cell surface associated | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MUC4 | Mucin 4, cell surface associated | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MYO7B | Myosin VIIB | Cytoskeleton related proteins
| | | | | Tissue enhanced |
NQO1 | NAD(P)H dehydrogenase, quinone 1 | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
ONECUT2 | One cut homeobox 2 | Transcription factors
| | | | | Tissue enhanced |
PADI2 | Peptidyl arginine deiminase, type II | Enzymes
| | | | | Tissue enhanced |
PKIB | Protein kinase (cAMP-dependent, catalytic) inhibitor beta | | | | | | Tissue enhanced |
PLS1 | Plastin 1 | | | | | | Tissue enhanced |
PRODH | Proline dehydrogenase (oxidase) 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Tissue enhanced |
PRR15 | Proline rich 15 | | | | | | Tissue enhanced |
PRR15L | Proline rich 15-like | | | | | | Tissue enhanced |
RAB27B | RAB27B, member RAS oncogene family | Plasma proteins
| | | | | Tissue enhanced |
RASEF | RAS and EF-hand domain containing | | | | | | Tissue enhanced |
REG1B | Regenerating islet-derived 1 beta | Predicted secreted proteins
| | | | | Tissue enhanced |
RFX6 | Regulatory factor X, 6 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
RNF186 | Ring finger protein 186 | Predicted membrane proteins
| | | | | Tissue enhanced |
RP11-1220K2.2 | Putative inactive maltase-glucoamylase-like protein LOC93432 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
RP11-407N17.3 | CTAGE family member 5 isoform 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
SCGN | Secretagogin, EF-hand calcium binding protein | Plasma proteins
| | | | | Tissue enhanced |
SCIN | Scinderin | Cytoskeleton related proteins Plasma proteins
| | | | | Tissue enhanced |
SCT | Secretin | Predicted secreted proteins
| | | | | Tissue enhanced |
SECTM1 | Secreted and transmembrane 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SLC23A1 | Solute carrier family 23 (ascorbic acid transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC28A2 | Solute carrier family 28 (concentrative nucleoside transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SMIM6 | Small integral membrane protein 6 | Predicted membrane proteins
| | | | | Tissue enhanced |
SOWAHA | Sosondowah ankyrin repeat domain family member A | Predicted secreted proteins
| | | | | Tissue enhanced |
SSTR1 | Somatostatin receptor 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
SULT1C2 | Sulfotransferase family, cytosolic, 1C, member 2 | Plasma proteins
| | | | | Tissue enhanced |
TFF3 | Trefoil factor 3 (intestinal) | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
TMC5 | Transmembrane channel-like 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
TMEM229A | Transmembrane protein 229A | Predicted membrane proteins
| | | | | Tissue enhanced |
TMEM45B | Transmembrane protein 45B | Predicted membrane proteins
| | | | | Tissue enhanced |
TNFRSF11A | Tumor necrosis factor receptor superfamily, member 11a, NFKB activator | CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
TPSD1 | Tryptase delta 1 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
TRPM5 | Transient receptor potential cation channel, subfamily M, member 5 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
TSPAN8 | Tetraspanin 8 | Cancer-related genes Predicted membrane proteins
| | | | | Tissue enhanced |
UPK1B | Uroplakin 1B | Predicted membrane proteins
| | | | | Tissue enhanced |
VDR | Vitamin D (1,25- dihydroxyvitamin D3) receptor | Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
VILL | Villin-like | Plasma proteins
| | | | | Tissue enhanced |
VIP | Vasoactive intestinal peptide | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enhanced |
ZG16 | Zymogen granule protein 16 | Predicted secreted proteins
| | | | | Tissue enhanced |